DE60038386D1 - Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben - Google Patents

Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben

Info

Publication number
DE60038386D1
DE60038386D1 DE60038386T DE60038386T DE60038386D1 DE 60038386 D1 DE60038386 D1 DE 60038386D1 DE 60038386 T DE60038386 T DE 60038386T DE 60038386 T DE60038386 T DE 60038386T DE 60038386 D1 DE60038386 D1 DE 60038386D1
Authority
DE
Germany
Prior art keywords
protein solution
hydrophobic resin
stabilizing
reservoir
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60038386T
Other languages
English (en)
Other versions
DE60038386T2 (de
Inventor
Nobuyuki Suzuki
Naoki Mitsui
Takaya Hiraishi
Yoshirou Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE60038386D1 publication Critical patent/DE60038386D1/de
Application granted granted Critical
Publication of DE60038386T2 publication Critical patent/DE60038386T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
DE60038386T 1999-09-08 2000-09-08 Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben Expired - Lifetime DE60038386T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25489699 1999-09-08
JP25489699 1999-09-08
PCT/JP2000/006144 WO2001017542A1 (fr) 1999-09-08 2000-09-08 Preparation de solution de proteines et procede de stabilisation associe

Publications (2)

Publication Number Publication Date
DE60038386D1 true DE60038386D1 (de) 2008-04-30
DE60038386T2 DE60038386T2 (de) 2009-04-23

Family

ID=17271358

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60038386T Expired - Lifetime DE60038386T2 (de) 1999-09-08 2000-09-08 Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben

Country Status (8)

Country Link
US (1) US7253142B1 (de)
EP (1) EP1232753B1 (de)
JP (3) JP5450508B2 (de)
AT (1) ATE389414T1 (de)
AU (1) AU6875900A (de)
DE (1) DE60038386T2 (de)
TW (1) TWI245645B (de)
WO (1) WO2001017542A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245645B (en) * 1999-09-08 2005-12-21 Chugai Pharmaceutical Co Ltd Protein solution formulations and stabilization methods thereof
ES2237574T5 (es) † 2000-05-15 2017-08-09 F. Hoffmann-La Roche Ag Composición farmacéutica líquida que contiene un derivado de eritropoyetina
CA2868614A1 (en) 2001-06-08 2002-12-08 Abbott Laboratories (Bermuda) Ltd. Methods of administering anti-tnf.alpha. antibodies
ES2325653T3 (es) 2001-12-21 2009-09-11 Novo Nordisk Health Care Ag Composicion liquida de polipeptidos del factor vii.
DK2283856T3 (da) 2002-06-21 2017-11-20 Novo Nordisk Healthcare Ag Stabiliserede, faste sammensætninger af Faktor VIIa-polypeptider
AU2003257536A1 (en) * 2002-08-27 2004-03-19 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein solution preparation
JP2006524195A (ja) * 2003-03-18 2006-10-26 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Ｖｉｉ因子ポリペプチドの液状水性医薬組成物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
MXPA05012476A (es) * 2003-05-23 2006-02-22 Novo Nordisk Healthcare Ag Estabilizacion de proteina en solucion.
CA2528988C (en) * 2003-06-10 2012-05-01 Lg Life Sciences Ltd. Stable, aqueous solution of human erythropoietin, not containing serum albumin
ATE547114T1 (de) 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
KR101293503B1 (ko) 2003-08-14 2013-08-07 노보 노르디스크 헬스 케어 악티엔게젤샤프트 인자 ｖｉｉ 폴리펩티드의 액상 수성 약학적 조성물
BRPI0417721B8 (pt) 2003-12-19 2021-05-25 Novo Nordisk Healthcare Ag kit contendo um medicamento farmacêutico, método para preparar uma formulação líquida de um fator recombinante viia, composição e métodos para preparar as composições
TWI556829B (zh) 2004-04-09 2016-11-11 艾伯維生物技術有限責任公司 用於治療ＴＮＦα相關失調症之多重可變劑量療法
JP2006182960A (ja) * 2004-12-28 2006-07-13 Nipro Corp 医療用潤滑剤およびこれを塗布したシリンジ
BRPI0610058A2 (pt) 2005-05-16 2010-05-25 Abbott Biotech Ltd uso de inibidor de tnf para tratamento da poliartrite erosiva
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
SG10201402265YA (en) * 2008-02-07 2014-08-28 Amgen Inc Stabilized protein compositions
WO2014100143A2 (en) * 2012-12-20 2014-06-26 Medimmune, Llc Liquid antibody formulation with improved aggregation properties
KR20220140025A (ko) 2013-03-12 2022-10-17 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 인간 파밀로마 바이러스용 개선된 백신 및 이것을 사용하는 방법
CN107106409A (zh) * 2014-10-02 2017-08-29 泰尔茂株式会社 用于容纳蛋白质溶液制剂的医疗用容器
EP3240630A1 (de) * 2014-12-31 2017-11-08 Koninklijke Philips N.V. Immobilisierung von modifiziertem oligonukleotid auf einem polymersubstrat über physisorption
ES2797298T3 (es) 2016-02-10 2020-12-01 Becton Dickinson France Procedimiento para evaluar la estabilidad de una formulación a base de proteína
EP3434251B1 (de) 2016-03-24 2023-08-16 Terumo Kabushiki Kaisha Arzneimittelbehälter
JP7153999B2 (ja) * 2016-04-22 2022-10-17 ロート製薬株式会社 水性組成物
JP7155003B2 (ja) * 2016-04-25 2022-10-18 テルモ株式会社 シリンジ用バレル及びプレフィルドシリンジ
JP7024730B2 (ja) 2016-12-22 2022-02-24 日本ゼオン株式会社 オリゴペプチドの探索方法、オリゴペプチド、修飾ペプチド、及び免疫測定方法
WO2019064263A1 (en) * 2017-09-29 2019-04-04 Janssen Biotech, Inc. NOVEL FORMULATIONS FOR STABILIZING LOW DOSE ANTIBODY COMPOSITIONS
JPWO2019225568A1 (ja) * 2018-05-21 2021-07-01 中外製薬株式会社 ガラス容器に封入された凍結乾燥製剤
CN112243423B (zh) 2018-05-28 2022-11-04 中外制药株式会社 填充喷嘴
US20210292402A1 (en) * 2018-07-31 2021-09-23 Zeon Corporation Pre-filled syringe and method of producing pre-filled syringe
WO2020026926A1 (ja) 2018-07-31 2020-02-06 日本ゼオン株式会社 プレフィルドシリンジおよびプレフィルドシリンジの製造方法
WO2021006057A1 (ja) 2019-07-05 2021-01-14 テルモ株式会社 タンパク質製剤を収納するための医薬品容器
US20230047299A1 (en) * 2020-01-28 2023-02-16 Zeon Corporation Pre-filled drug package and method of producing pre-filled drug package

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3788319A (en) * 1971-07-30 1974-01-29 Univ Iowa State Res Found Inc System for exchanging blood ultrafiltrate
JPS54135215A (en) * 1978-04-10 1979-10-20 Ss Pharmaceutical Co Stable aqueous lisozyme solution
US4732889A (en) 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
DE3777845D1 (de) 1986-01-22 1992-05-07 Chugai Pharmaceutical Co Ltd Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
US4838861A (en) * 1986-05-02 1989-06-13 Sharp David E Blood preservation by ultrahemodilution
JP2629000B2 (ja) * 1986-07-18 1997-07-09 中外製薬株式会社 安定な顆粒球コロニー刺激因子含有製剤
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
US4810249A (en) * 1987-03-12 1989-03-07 Habley Medical Technology Corp. Linear and Vernier-type syringe
DE3729863A1 (de) 1987-09-05 1989-03-16 Boehringer Mannheim Gmbh Stabilisierte erythropoietin-lyophilisate
US5728437A (en) 1987-08-26 1998-03-17 Astra Meditec Aktiebolag Articles exhibiting a blood-compatible surface layer and process for providing articles with such a surface layer
SE8703310D0 (sv) 1987-08-26 1987-08-26 Astra Meditec Ab Articles exhibiting a blood-compatible surface layer and process for providing articles with such a surface layer
ES2008948A6 (es) * 1988-01-07 1989-08-16 Martinez Gimeno Carlos Vicente Jeringa de un solo uso auto-inutilizable.
US5213814A (en) * 1989-04-10 1993-05-25 Cryopharm Corporation Lyophilized and reconstituted blood platelet compositions
JPH0669956B2 (ja) * 1988-09-30 1994-09-07 旭化成工業株式会社 ポリペプタイド類の吸着防止剤
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
ATE145661T1 (de) 1991-07-22 1996-12-15 Daikyo Gomu Seiko Kk Behälter für hygienische artikel
US5571788A (en) 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
DE69330107T3 (de) 1992-02-12 2004-12-30 Daikyo Gomu Seiko, Ltd. Medizinisches Gerät
US6007520A (en) 1992-02-12 1999-12-28 Daikyo Gomu Seiko, Ltd. Medical instrument
JP3666884B2 (ja) * 1992-05-21 2005-06-29 日本ゼオン株式会社 医療用器材
US5468803A (en) 1992-03-03 1995-11-21 Nippon Zeon Co. Ltd. Medical implement, polymer composition, and optical material
DE69333924T2 (de) * 1992-05-29 2006-08-17 University Of North Carolina At Chapel Hill Im immobilisierten Zustand getrocknete pharmazeutisch verträgliche menschliche Blutplättchen
JP3895782B2 (ja) * 1992-10-26 2007-03-22 生化学工業株式会社 コンドロイチナーゼ組成物およびそれを含有する注射用製剤
US5496718A (en) 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
NZ260909A (en) 1993-07-05 1995-04-27 Takeda Chemical Industries Ltd Production of sustained release preparation by allowing a water-soluble polypeptide to permeate into a biodegradable matrix in an aqueous solution
JP2747979B2 (ja) * 1994-08-19 1998-05-06 雪印乳業株式会社 ヒト由来の糖蛋白質からなる生理活性因子を有効成分とする医薬
JPH08155007A (ja) * 1994-12-02 1996-06-18 Mitsui Petrochem Ind Ltd 薬剤充填容器製剤及びこれに用いる容器
TW434020B (en) 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
BE1009403A3 (fr) 1995-06-02 1997-03-04 Solvay Composition souple a base de polymere de chlorure de vinyle, utilisation de cette composition pour la fabrication d'un article et article comprenant cette composition.
TWI240627B (en) 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
PT954272E (pt) * 1996-12-23 2002-09-30 Novo Nordisk As Recipiente em polimere de hidrocarboneto ciclico para armazenagem de medicamento liquido
JP3480672B2 (ja) * 1997-04-25 2003-12-22 稔 寺野 生体適合性ポリオレフィン成形品、及び生体適合性高分子材料
JP3387775B2 (ja) * 1997-05-22 2003-03-17 株式会社大協精工 注射器用密封栓及びプレフィルド注射器
JP3568398B2 (ja) * 1997-09-11 2004-09-22 中外製薬株式会社 アポトーシスを誘起するモノクローナル抗体
JP3103535B2 (ja) * 1998-05-29 2000-10-30 大洋薬品工業株式会社 カルシトニン類のプレフィルドシリンジ製剤
WO2000015241A1 (fr) 1998-09-11 2000-03-23 Chugai Seiyaku Kabushiki Kaisha Preparation d'une solution proteinique et son procede de stabilisation
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
TWI245645B (en) * 1999-09-08 2005-12-21 Chugai Pharmaceutical Co Ltd Protein solution formulations and stabilization methods thereof
JP5765281B2 (ja) * 2012-03-27 2015-08-19 株式会社Ｊｖｃケンウッド 復号装置、復号方法、及び、プログラム

Also Published As

Publication number Publication date
JP2014051502A (ja) 2014-03-20
WO2001017542A1 (fr) 2001-03-15
US7253142B1 (en) 2007-08-07
EP1232753A1 (de) 2002-08-21
EP1232753A4 (de) 2004-08-11
ATE389414T1 (de) 2008-04-15
TWI245645B (en) 2005-12-21
EP1232753B1 (de) 2008-03-19
JP2016056176A (ja) 2016-04-21
JP6076226B2 (ja) 2017-02-08
JP2011168610A (ja) 2011-09-01
DE60038386T2 (de) 2009-04-23
JP6134370B2 (ja) 2017-05-24
AU6875900A (en) 2001-04-10
JP5450508B2 (ja) 2014-03-26

Similar Documents

Publication Publication Date Title
DE60038386D1 (de) Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben
ATE277630T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
DE69839241D1 (de) Haltevorrichtung zur Herstellung von Präzisionsteilen
ATE293413T1 (de) Implantat aus knochenmaterial
DE60116322D1 (de) Vorrichtung zur aktiven kompensation von aberrationen in einem optischen system
PT799030E (pt) Formulacoes em po contendo melezitose como diluente
DE60107714D1 (de) Behälter zur kombinierten entgasung und flotation
ATE241264T1 (de) Stützvorrichtung zur abgabe von flüchtigen stoffen
DE60223956D1 (de) Untersuchungsgerät und System zur Untersuchung von Fremdkörpern in mit Flüssigkeit gefüllten Behältern
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
ATE428495T1 (de) Stoffe zur enternung von cannabinoiden und säulen mit diesen stoffen zur entfernung von cannabinoiden
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
HK1098767A1 (en) Biologically active peptides
DE60141616D1 (de) Verfahren zur Herstellung von kleinen, sphärischen Siliconharzpartikeln
KR900005944A (ko) 골 재생물질 및 인공 골 고정제
DE60234142D1 (de) Albuminlösung enthaltender Kunststoffbehälter
EP1273523A4 (de) Kunststoffbehälter für flüchtige organische substanzen enthaltenden flüssigkeiten
ITVE20020012A1 (it) Emanatore elettrico di deodorante o di insetticida.
DE60045894D1 (de) Extraktion von polysaccharide aus algenprotein und verwendung davon
ATE109950T1 (de) Verwendung von geschützten aminosäuren in futtermitteln für schafe.
CO4950572A1 (es) Procedimiento y dispositivos para la emision constante de liquidos volatiles
ES2177258T3 (es) Procedimiento parra la extraccion de particulas de poliamida 6.
ATE301394T1 (de) Porenformender gegenstand zur beseitigung schädlicher mirkoorganismen und verfahren zu seiner herstellung
ATE396604T1 (de) Material für elektrolumineszente vorrichtung und elektrolumineszente vorrichtung damit
DE69814045D1 (de) Einweg-sicherheitsvorrichtung zur blutübertragung

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: WATANABE, YOSHIROU, TOKYO, JP

Inventor name: HIRAISHI, TAKAYA, TOKYO, JP

Inventor name: MITSUI, NAOKI, TOKYO, JP

Inventor name: SUZUKI, NOBUYUKI, TOKYO, JP

8364 No opposition during term of opposition